跳至主要内容
临床试验/NCT03436277
NCT03436277Unknown2 期

Effect of the Administration of L-Carnitine on Body Fat Percentage and Body Weight in Overweight Women in Crossfit Training.

University of Guadalajara1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
24
试验地点
1
主要终点
Body Fat

研究概览

简要总结

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.

详细描述

A randomized, double-blind, placebo-controlled clinical trial will be carry out in 24 woman with body mass index ≥ 25 to 29.9 kg/m2. The patients will receive 1.5 g of L-Carnitine deluded in 250 ml of water or placebo before crossfit training, 5 times a week for 8 weeks. Before and after intervention the investigators evaluate: The body composition (body fat, lean body mass), arm muscle circumference, waist circumference, body weight and body mass index.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Volunteers who practice crossfit regularly (who have 3 months prior to the beginning of the study practicing crossfit).
  • Volunteers with a body mass index equal to or greater than 25 Kg/m
  • Volunteers who do not have allergies to L-Carnitine or any of its components.
  • Informed consent signed
  • Women with a recommendation of nutrition two weeks prior to the start of the study.
  • Body weight stable the last 3 months.

排除标准

  • Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and allergies.
  • Women with confirmed or suspected pregnancy.
  • Women under lactation and/or puerperium.
  • Hypersensibilility to L-Carnitine or Sucralose.
  • Kown of renal, hepatic or thyroid deseased.
  • Current or previous treatment diet (3 months before inclusion to the study).
  • Current pharmacological treatment for loose body weight or 3 months before inclusion to the study.

研究组 & 干预措施

Placebo

Placebo Comparator

Sucralose 1,5 g

干预措施: Sucralose (Dietary Supplement)

L-Carnitine

Experimental

L- Carnitine 1,5 g

干预措施: L-Carnitine (Drug)

结局指标

主要结局

Body Fat

时间窗: 8 weeks

Calulated by Durnin formula. Results are reported in percentage and kg

Body Weight

时间窗: 8 weeks

Subject go up onto the scale and stand still over the center of the scale with body weight evenly distributed between both feet. Omron hbf-514c an digital scale and results are reported in kg with a decimal.

Lean body mass

时间窗: 8 weeks

Calulated by Durnin formula. Results are reported in percentage and kg

次要结局

  • Body Mass Index(8 weeks)
  • Arm muscle circumference(8 weeks)
  • Waist circumference(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diana Mercedes Hernández Corona

PhD of Pharmacology

University of Guadalajara

研究点 (1)

Loading locations...

相似试验

Effect of the Administration of L-Carnitine on Body... | 临床试验